MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy

Pain Clinical Trial

Official title: MC15C1 Randomized Scrambler Therapy vs TENS for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Status Completed

Clinical Trial Summary

This randomized clinical trial studies how well MC5-A scrambler therapy or transcutaneous electrical nerve stimulation (TENS) therapy work in treating patients with chemotherapy-induced peripheral neuropathy (a nerve problem that causes pain, numbness, tingling, swelling, or muscle weakness in different parts of the body). MC5-A scrambler therapy is a type of treatment for nerve pain that uses electrodes placed on the skin, where electricity is carried from the electrodes through the skin and blocks the pain. TENS is a procedure in which mild electric currents are applied to some areas of the skin. It is not yet known whether TENS therapy is more effective than MC5-A scrambler therapy in treating chemotherapy-induced peripheral neuropathy.

Clinical Trial Description

PRIMARY OBJECTIVES: I. Evaluate the efficacy of scrambler therapy (MC5-A scrambler therapy) compared to TENS therapy for pain and/or tingling related to chemotherapy-induced peripheral neuropathy (CIPN). II. Evaluate the tolerability of scrambler therapy and compare it to TENS therapy, in this population. III. Evaluate whether scrambler therapy, compared to TENS therapy, can decrease the use of pain medication for CIPN. IV. Explore whether messenger ribonucleic acid (mRNA) gene expression before and after scrambler therapy shows similar findings to what Starkweather et al observed. V. Utilizing high-field magnetic resonance imaging (MRI), to define alterations in functional differences (using resting state blood-oxygen-level dependent [BOLD] measures to measure differences in functional connectivity) in treated with the scrambler device in the setting of chemotherapy induced peripheral neuropathy pain. VI. Explore whether scrambler therapy will alter sensation. OUTLINE: Patients are randomized to 1 of 2 treatment arms. ARM I: Patients undergo MC5-A scrambler therapy over 30 minutes for 10 consecutive weekdays. ARM II: Patients undergo TENS therapy over 30 minutes daily for 14 days. Patients in both Arms, may crossover to the opposite Arm for an additional 2 weeks of treatment if they elect. After completion of study treatment, patients are followed up weekly for 8 weeks. ;

Related Conditions & MeSH terms

• Pain
• Peripheral Nervous System Diseases
• Peripheral Neuropathy
• Tingling

• NCT number: NCT02722434
• Study type: Interventional
• Source: Mayo Clinic
• Status: Completed
• Phase: N/A
• Start date: April 13, 2016
• Completion date: August 26, 2021